Market Cap

$345.9B

Volume

7.1M

Cash and Equivalents

$20.0B

EBITDA

$30.1B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$60.9B

Profit Margin

69.39%

52 Week High

$168.85

52 Week Low

$142.75

Dividend

3.45%

Price / Book Value

4.93

Price / Earnings

23.64

Price / Tangible Book Value

-24.47

Enterprise Value

$361.3B

Enterprise Value / EBITDA

11.94

Operating Income

$23.1B

Return on Equity

20.89%

Return on Assets

8.40

Cash and Short Term Investments

$20.3B

Debt

$35.8B

Equity

$70.2B

Revenue

$87.7B

Unlevered FCF

$20.4B

Sector

Pharmaceuticals

Category

N/A